Home » Authors » Karen Carey

Karen Carey

Articles

ARTICLES

Guilford Acquires ProQuest For Ownership Of Aquavan

Dec. 3, 2004

FDA OKs AnorMed's SPA For Pivotal Stem Cell Trials

Dec. 3, 2004

Intarcia Raises $50M ViaSeries E For Atamestane

Dec. 2, 2004

Metabolex's $44M Round To Advance Diabetes Drug

Dec. 1, 2004

Achillion Could Get $110M In Gilead HCV Agreement

Nov. 30, 2004

BioMarin Secures Access To Phenoptin Data, Supply

Nov. 29, 2004

Medarex Partnering Lupus Antibodies With MedImmune

Nov. 24, 2004

VaxGen Raises $40M For Anthrax Vaccine Contract

Nov. 23, 2004

Transport's $27M Series D For Pivotal Program Funds

Nov. 23, 2004

Synta Attracts $80M In Series D To Move Clinical Products Along

Nov. 22, 2004

View All Articles by Karen Carey

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...